Ratings by Canaccord Genuity (Whitney Ijem)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/9/2023 | Tenaya Therapeutics Inc | TNYA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Hold (N/A) |
|
Details | ||
| 2/23/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Vertex | VRTX | Maintain | Hold (N/A) |
|
Details | ||
| 1/18/2023 | Sigilon Therapeutics | SGTX | New Coverage | Buy (N/A) |
0.41 (0.94) |
129.27% | Details | |
| 1/18/2023 | Vertex | VRTX | New Coverage | Hold (N/A) |
311.98 (314.24) |
0.72% | Details | |
| 1/18/2023 | Alnylam Pharmaceuticals | ALNY | New Coverage | Buy (N/A) |
233.73 (195.91) |
-16.18% | Details | |
| 1/18/2023 | Ultragenyx Pharma | RARE | New Coverage | Buy (N/A) |
42.50 (39.07) |
-8.07% | Details | |
| 1/18/2023 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Hold (N/A) |
111.72 (94.20) |
-15.68% | Details | |
| 1/18/2023 | Rhythm Pharmaceuticals | RYTM | New Coverage | Buy (N/A) |
30.27 (17.44) |
-42.39% | Details | |
| 11/8/2022 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
1.99 (0.65) |
-67.34% | Details | |
| 11/8/2022 | Tenaya Therapeutics Inc | TNYA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Regulus Therapeutics | RGLS | New Coverage | Buy (N/A) |
1.46 (0.82) |
-43.84% | Details | |
| 11/8/2022 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
17.01 (16.75) |
-1.53% | Details | |
| 11/8/2022 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
5.96 (4.87) |
-18.29% | Details | |
| 11/8/2022 | Passage Bio Inc. | PASG | New Coverage | Buy (N/A) |
1.24 (0.99) |
-20.16% | Details |
